← Back
$RLMD All transactions

RELMADA THERAPEUTICS, INC.

▲ BUY
10 / 10

Conviction

$ Value

$31K

Shares

60,000

Price

$1

Filed

May 20

Why this score? (10/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Shenouda Maged

Title

Chief Financial Officer

CIK

0001658369

Roles

Officer

Transaction Details

Transaction Date

2025-05-20

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

288,335

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. | Purchase prices range from $0.4229 to $0.4674 per share, inclusive. | Purchase prices range from $0.4493 to $0.4998 per share, inclusive. | Purchase prices range from $0.4998 to $0.5396 per share, inclusive.

Filing Info

Accession No.

0001213900-25-046087

Form Type

4

Issuer CIK

0001553643

Shenouda Maged's History

Date Ticker Type Value
2025-12-15 RLMD $48K
2025-12-12 RLMD A $0
2025-11-05 RLMD $1.1M
2025-06-26 RLMD A $0
2025-05-20 RLMD $31K
2025-05-19 RLMD $44K
2025-05-16 RLMD $22K

Other Insiders at RLMD (90d)

No other insider activity at this issuer in the last 90 days.